---
figid: PMC3120937__WJG-17-2781-g001
figlink: /pmc/articles/PMC3120937/figure/F1/
number: F1
caption: 'Signalling pathways in oesophageal adenocarcinoma. The pathways known to
  be operative in oesophageal adenocarcinoma are A: PI3-Kinase, B: Mitogen activated
  protein (MAP) Kinase, C: Wnt signalling and D: Nuclear factor-κB (NF-κB). The green
  arrows indicate activation, the red arrows indicate inhibition. Vascular epidermal
  growth factor (VEGF), human epidermal growth factor receptor 2 (HER2), epidermal
  growth factor receptor 1 (EGFR), insulin growth factor receptor (IGFR), hepatocyte
  growth factor receptor (MET), platelet derived growth factor receptor (PDGFR) and
  fibroblast growth factor receptor (FGFR) are the known receptor tyrosine kinase
  (RTK) associated with oesophageal adenocarcinomas. The pathways are complex and
  inter-connected. For example RTKs can activate all 4 known pathways. The ultimate
  biological response varies from cell proliferation, development, apoptosis, differentiation,
  inflammatory response, angiogenesis and invasion depending on which specific pathway
  or receptor is activated. A: PI3-Kinase pathway. RTK activates PI3-Kinase directly
  or through RAS. As a consequence of phosphorylation, PI3K recruits AKT. AKT inhibits
  tuberin, this allows activation of the Raptor/mTOR complex to activate transcriptional
  machinery. mTOR/raptor activates transcription factors and co-activator proteins
  cMyc and hypoxia inducible factor (HIF)-1α that drive the biological response of
  growth, proliferation, glycolysis, angiogenesis and invasion; B: MAP Kinase pathways.
  The 3 main MAP Kinase pathways are extracellular related kinase (ERK), p38 and JUN
  kinase (JNK). They are all activated by similar RTKs. The signalling pathways have
  a common feature of a cascade of phospho-proteins. A MAPKK Kinase (e.g. RAF), a
  MAPK Kinase [e.g. MAP ERK kinase (MEK)1/2] and a MAP Kinase (eg. ERK) transfer the
  signal onto multiple transcription factors on gene promoters[]. ERK signalling for
  example can alter the gene expression of over 200 genes[]. The subsequent biological
  response varies from cell proliferation, development, apoptosis, differentiation
  and inflammatory response, depending on the specific pathway activated; C: Wnt signalling.
  Wnt signalling exerts a biological response through release of β catenin into the
  nucleus with subsequent action on gene promoters. β catenin is released directly
  from RTK phosphorylation of Axin. Alternatively Wnt ligands bind to Frizzled receptors
  and form a complex with the LRP5/6 membrane receptor. The membrane receptor complex
  recruits dishevelled and axin from a cytoplasmic complex of dishevelled, Axin, adenomatous
  polyposis coli protein (APC) and β catenin. This allows release of β catenin; D:
  NF-κB pathway. NF-κB (p65p50) activates gene promoters only when released from IκB.
  Interleukin-8 (IL-8), tumour necrosis factor (TNF)α and radiation activate the pathway.
  Adding to complexity, ERK MAP Kinase and Wnt, through protein Kinase C, can also
  potentially activate NF-κB although this link has not been investigated in oesophageal
  adenocarcinoma.'
pmcid: PMC3120937
papertitle: 'Targeting key signalling pathways in oesophageal adenocarcinoma: A reality
  for personalised medicine?.'
reftext: Richard R Keld, et al. World J Gastroenterol. 2011 Jun 21;17(23):2781-2790.
pmc_ranked_result_index: '60389'
pathway_score: 0.9439318
filename: WJG-17-2781-g001.jpg
figtitle: Signalling pathways in oesophageal adenocarcinoma
year: '2011'
organisms: Homo sapiens
ndex: f916df68-def9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3120937__WJG-17-2781-g001.html
  '@type': Dataset
  description: 'Signalling pathways in oesophageal adenocarcinoma. The pathways known
    to be operative in oesophageal adenocarcinoma are A: PI3-Kinase, B: Mitogen activated
    protein (MAP) Kinase, C: Wnt signalling and D: Nuclear factor-κB (NF-κB). The
    green arrows indicate activation, the red arrows indicate inhibition. Vascular
    epidermal growth factor (VEGF), human epidermal growth factor receptor 2 (HER2),
    epidermal growth factor receptor 1 (EGFR), insulin growth factor receptor (IGFR),
    hepatocyte growth factor receptor (MET), platelet derived growth factor receptor
    (PDGFR) and fibroblast growth factor receptor (FGFR) are the known receptor tyrosine
    kinase (RTK) associated with oesophageal adenocarcinomas. The pathways are complex
    and inter-connected. For example RTKs can activate all 4 known pathways. The ultimate
    biological response varies from cell proliferation, development, apoptosis, differentiation,
    inflammatory response, angiogenesis and invasion depending on which specific pathway
    or receptor is activated. A: PI3-Kinase pathway. RTK activates PI3-Kinase directly
    or through RAS. As a consequence of phosphorylation, PI3K recruits AKT. AKT inhibits
    tuberin, this allows activation of the Raptor/mTOR complex to activate transcriptional
    machinery. mTOR/raptor activates transcription factors and co-activator proteins
    cMyc and hypoxia inducible factor (HIF)-1α that drive the biological response
    of growth, proliferation, glycolysis, angiogenesis and invasion; B: MAP Kinase
    pathways. The 3 main MAP Kinase pathways are extracellular related kinase (ERK),
    p38 and JUN kinase (JNK). They are all activated by similar RTKs. The signalling
    pathways have a common feature of a cascade of phospho-proteins. A MAPKK Kinase
    (e.g. RAF), a MAPK Kinase [e.g. MAP ERK kinase (MEK)1/2] and a MAP Kinase (eg.
    ERK) transfer the signal onto multiple transcription factors on gene promoters[].
    ERK signalling for example can alter the gene expression of over 200 genes[].
    The subsequent biological response varies from cell proliferation, development,
    apoptosis, differentiation and inflammatory response, depending on the specific
    pathway activated; C: Wnt signalling. Wnt signalling exerts a biological response
    through release of β catenin into the nucleus with subsequent action on gene promoters.
    β catenin is released directly from RTK phosphorylation of Axin. Alternatively
    Wnt ligands bind to Frizzled receptors and form a complex with the LRP5/6 membrane
    receptor. The membrane receptor complex recruits dishevelled and axin from a cytoplasmic
    complex of dishevelled, Axin, adenomatous polyposis coli protein (APC) and β catenin.
    This allows release of β catenin; D: NF-κB pathway. NF-κB (p65p50) activates gene
    promoters only when released from IκB. Interleukin-8 (IL-8), tumour necrosis factor
    (TNF)α and radiation activate the pathway. Adding to complexity, ERK MAP Kinase
    and Wnt, through protein Kinase C, can also potentially activate NF-κB although
    this link has not been investigated in oesophageal adenocarcinoma.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RELA
  - RELB
  - MTOR
  - REL
  - MAPK9
  - NFKB1
  - MAPK8
  - PIK3CG
  - CDK9
  - MAP3K5
  - MAP2K7
  - TSC2
  - MAPK10
  - MAP3K11
  - PDGFRA
  - MAPK11
  - MAPK12
  - CXCL8
  - MAP2K3
  - FZD9
  - ERBB2
  - MAP2K4
  - PRKCQ
  - LRP6
  - TNF
  - IGF1R
  - WNT2
  - MAPK14
  - BRAF
  - ARAF
  - WNT16
  - RPTOR
  - NRAS
  - KRAS
  - HRAS
  - PRKD3
  - PRKCA
  - LRP5
  - MAP3K4
  - NFKB2
  - MAP2K6
  - FLT4
  - WNT5A
  - AKT1
  - AKT3
  - PDGFRB
  - WNT4
  - WNT1
  - MAP3K12
  - EGFR
  - PRKCB
  - PRKCD
  - MAP3K1
  - MAPK13
  - RAF1
  - AKT2
  - PRKCZ
  - PRKCI
  - FZD7
  - FZD8
  - FZD1
  - FZD3
  - WNT10A
  - PIK3R6
  - WNT3A
  - MAP2K1
  - MET
  - KDR
  - PIK3CB
  - PIK3R3
  - PRKCH
  - FZD6
  - FZD2
  - CTNNB1
  - WNT9A
  - WNT9B
  - WNT5B
  - WNT3
  - PIK3R5
  - FLT1
  - PRKCG
  - PIK3CA
  - WNT7B
  - WNT8B
  - WNT10B
  - WNT11
  - FZD5
  - FGFR2
  - FGFRL1
  - FZD10
  - APC
  - WNT7A
  - MAP2K2
  - PRKCE
  - FGFR1
  - WNT2B
  - WNT8A
  - FGFR4
  - FZD4
  - MAPK1
  - FGFR3
  - WNT6
  - PIK3CD
  - PIK3R4
  - MAPK3
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: MTOR/
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: SAPK/JNK
  symbol: SAPK
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: SAPK/JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: SAPK/JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: TAK,
  symbol: TAK
  source: hgnc_alias_symbol
  hgnc_symbol: CDK9
  entrez: '1025'
- word: MLK3,ASK1
  symbol: ASK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP3K5
  entrez: '4217'
- word: MKK4/7
  symbol: MKK7
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K7
  entrez: '5609'
- word: Tuberin
  symbol: tuberin
  source: hgnc_alias_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: SAPK/JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MLK3,
  symbol: MLK3
  source: hgnc_prev_symbol
  hgnc_symbol: MAP3K11
  entrez: '4296'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: IL-8
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: MKK3/6
  symbol: MKK3
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K3
  entrez: '5606'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: MKK4/7
  symbol: MKK4
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K4
  entrez: '6416'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: LRP5/6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
- word: TNFa
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IGFR
  symbol: IGFR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: raptor
  symbol: raptor
  source: hgnc_alias_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: LRP5/6
  symbol: LRP5
  source: hgnc_symbol
  hgnc_symbol: LRP5
  entrez: '4041'
- word: MEKK1/4,
  symbol: MEKK4
  source: hgnc_prev_symbol
  hgnc_symbol: MAP3K4
  entrez: '4216'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: MKK3/6
  symbol: MKK6
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K6
  entrez: '5608'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: DLK
  symbol: DLK
  source: hgnc_alias_symbol
  hgnc_symbol: MAP3K12
  entrez: '7786'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: MEKK1/4,
  symbol: MEKK1
  source: hgnc_prev_symbol
  hgnc_symbol: MAP3K1
  entrez: '4214'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: Bcatenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3120937__F1
redirect_from: /figures/PMC3120937__F1
figtype: Figure
---
